241 related articles for article (PubMed ID: 23603907)
1. FOXO3 growth inhibition of colonic cells is dependent on intraepithelial lipid droplet density.
Qi W; Fitchev PS; Cornwell ML; Greenberg J; Cabe M; Weber CR; Roy HK; Crawford SE; Savkovic SD
J Biol Chem; 2013 Jun; 288(23):16274-16281. PubMed ID: 23603907
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor mediated proliferation depends on increased lipid droplet density regulated via a negative regulatory loop with FOXO3/Sirtuin6.
Penrose H; Heller S; Cable C; Makboul R; Chadalawada G; Chen Y; Crawford SE; Savkovic SD
Biochem Biophys Res Commun; 2016 Jan; 469(3):370-6. PubMed ID: 26657850
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor FOXO3 mediates signals from the EGF receptor to regulate proliferation of colonic cells.
Qi W; Weber CR; Wasland K; Roy H; Wali R; Joshi S; Savkovic SD
Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G264-72. PubMed ID: 21109589
[TBL] [Abstract][Full Text] [Related]
4. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.
Qi W; Weber CR; Wasland K; Savkovic SD
BMC Cancer; 2011 Jun; 11():219. PubMed ID: 21639915
[TBL] [Abstract][Full Text] [Related]
5. Intestinal inflammation requires FOXO3 and prostaglandin E2-dependent lipogenesis and elevated lipid droplets.
Heller S; Cable C; Penrose H; Makboul R; Biswas D; Cabe M; Crawford SE; Savkovic SD
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(10):G844-54. PubMed ID: 26968210
[TBL] [Abstract][Full Text] [Related]
6. Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel Targets.
Penrose HM; Cable C; Heller S; Ungerleider N; Nakhoul H; Baddoo M; Hartono AB; Lee SB; Burow ME; Flemington EF; Crawford SE; Savkovic SD
Cell Mol Gastroenterol Hepatol; 2019; 7(2):391-408. PubMed ID: 30718226
[TBL] [Abstract][Full Text] [Related]
7. FOXO3: at the crossroads of metabolic, inflammatory, and tumorigenic remodeling in the colon.
Snarski P; Ghimire J; Savkovic SD
Am J Physiol Gastrointest Liver Physiol; 2024 Mar; 326(3):G247-G251. PubMed ID: 38193202
[TBL] [Abstract][Full Text] [Related]
8. FOXO3 Deficiency in Neutrophils Drives Colonic Inflammation and Tumorigenesis.
Ghimire J; Iftikhar R; Penrose HM; Snarski P; Ruiz E; Savkovic SD
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298680
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor FOXO3 participates in the regulation of intestinal inflammation.
Snoeks L; Weber CR; Wasland K; Turner JR; Vainder C; Qi W; Savkovic SD
Lab Invest; 2009 Sep; 89(9):1053-62. PubMed ID: 19636295
[TBL] [Abstract][Full Text] [Related]
10. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
Ghosh S; Singh R; Vanwinkle ZM; Guo H; Vemula PK; Goel A; Haribabu B; Jala VR
Theranostics; 2022; 12(12):5574-5595. PubMed ID: 35910798
[TBL] [Abstract][Full Text] [Related]
11. New insights into the roles of the
Mayahi S; Golalipour M; Yamchi A; Jhingan GD; Shahbazi M
Ups J Med Sci; 2019 Aug; 124(3):149-157. PubMed ID: 31294654
[No Abstract] [Full Text] [Related]
12. MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells.
Liu R; Liu F; Li L; Sun M; Chen K
Biomed Pharmacother; 2015 May; 72():52-7. PubMed ID: 26054675
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity.
Hu JQ; Deng F; Hu XP; Zhang W; Zeng XC; Tian XF
Oncol Rep; 2018 Dec; 40(6):3635-3644. PubMed ID: 30542728
[TBL] [Abstract][Full Text] [Related]
14. Colonic PDGFRα Overexpression Accompanied Forkhead Transcription Factor FOXO3 Up-Regulation in STZ-Induced Diabetic Mice.
Lu H; Zhang C; Song N; Lu C; Tong L; Huang X; Kim YC; Chen J; Xu W
Cell Physiol Biochem; 2017; 43(1):158-171. PubMed ID: 28848093
[TBL] [Abstract][Full Text] [Related]
15. Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression.
Gao Z; Li Z; Liu Y; Liu Z
Mol Genet Genomic Med; 2019 Mar; 7(3):e554. PubMed ID: 30623608
[TBL] [Abstract][Full Text] [Related]
16. Effects of high-fat diet and intestinal aryl hydrocarbon receptor deletion on colon carcinogenesis.
Garcia-Villatoro EL; DeLuca JAA; Callaway ES; Allred KF; Davidson LA; Hensel ME; Menon R; Ivanov I; Safe SH; Jayaraman A; Chapkin RS; Allred CD
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G451-G463. PubMed ID: 31905023
[TBL] [Abstract][Full Text] [Related]
17. Zinc finger protein 277 is an intestinal transit-amplifying cell marker and colon cancer oncogene.
Xie G; Peng Z; Liang J; Larabee SM; Drachenberg CB; Yfantis H; Raufman JP
JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35015732
[TBL] [Abstract][Full Text] [Related]
18. Repression of MLH1 and MGMT genes in colon mucosa adjacent to implanted cancer in athymic mouse.
Kuniyasu H; Sasaki T; Sasahira T; Chihara Y; Ohmori H
J Exp Clin Cancer Res; 2004 Jun; 23(2):317-23. PubMed ID: 15354418
[TBL] [Abstract][Full Text] [Related]
19. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis.
Ciaparrone M; Yamamoto H; Yao Y; Sgambato A; Cattoretti G; Tomita N; Monden T; Rotterdam H; Weinstein IB
Cancer Res; 1998 Jan; 58(1):114-22. PubMed ID: 9426067
[TBL] [Abstract][Full Text] [Related]
20. CacyBP/SIP promotes the proliferation of colon cancer cells.
Zhai H; Shi Y; Chen X; Wang J; Lu Y; Zhang F; Liu Z; Lei T; Fan D
PLoS One; 2017; 12(2):e0169959. PubMed ID: 28196083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
